Effects of Transcranial Photobiomodulation in ADHD
Recruiting · NCT07203092 · Interventional (participants receive a specific treatment) · Lead sponsor: Francisco Gonzalez-Lima, PhD
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.
Who can take part
Inclusion criteria
- English-speaking
- Adults of any sex
- Age range: 18-44 years
- Any ethnic/racial background
- Medical history of ADHD
- Participants may either be on a stable ADHD medication regimen (with no changes within two weeks prior to the study) or not taking medication.
Exclusion criteria
- Currently pregnancy
- Any sham or active photobiomodulation treatment within the past five weeks.
Where it is running
1 location listed across 1 US state.
- The University of Texas at Austin - Austin, Texas, United States